Provided by Tiger Trade Technology Pte. Ltd.

Cara Therapeutics

5.32
0.0000
Volume:- -
Turnover:- -
Market Cap:1.26B
PE:- -
High:5.32
Open:5.32
Low:5.32
Close:5.32
52wk High:19.08
52wk Low:5.32
Shares:236.13M
Float Shares:3.12M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(LYR):-26.2637
ROE:-270.01%
ROA:-41.09%
PB:-273.50
PE(LYR):-0.20

Loading ...

Apr 15, 2025

Major Issues Report

Form 8-K - Current report
Apr 11, 2025

Major Issues Report

Form 8-K - Current report
Apr 02, 2025

Major Issues Report

Form 8-K - Current report
Mar 24, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Mar 24, 2025

Major Issues Report

Form 8-K - Current report
Mar 12, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 21, 2025

Major Issues Report

Form 8-K - Current report
Jan 21, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jan 17, 2025

Major Issues Report

Form 8-K - Current report
Jan 17, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Dec 30, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Dec 30, 2024

Major Issues Report

Form 8-K - Current report
Dec 20, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Dec 20, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Dec 18, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Dec 18, 2024

Major Issues Report

Form 8-K - Current report
Nov 22, 2024

Major Issues Report

Form 8-K - Current report
Nov 15, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 30, 2024

Beneficial Ownership Change

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Aug 15, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]